Methadone-involved overdose deaths in the US before and after federal policy changes expanding take-home methadone doses from opioid treatment programs
Saved in:
PharmD, C.M.J., Methadone-involved overdose deaths in the US before and after federal policy changes expanding take-home methadone doses from opioid treatment programs. JAMA Psychiatric, online, 2022, 3 p.
Ref.
577444
Palabras clave:
Drogodependiente, Metadona, Sobredosis, Mortalidad, COVID, Tratamiento, Opiáceos, Efectos no deseados, Datos estadísticos, EE.UU.
Drogodependiente, Metadona, Sobredosis, Mortalidad, COVID, Tratamiento, Opiáceos, Efectos no deseados, Datos estadísticos, EE.UU.
Similar Items: Methadone-involved overdose deaths in the US before and after federal policy changes expanding take-home methadone doses from opioid treatment programs
- The impact of relaxing restrictions on take-home doses during the COVID-19 pandemic on program effectiveness and client experiences in opioid agonist treatment: a mixed methods systematic review
- Preventing opioid overdose deaths with take-home naloxone
- CONTINGENT METHADONE TAKE-HOME DOSES REINFORCE ADJUNCT THERAPY ATTENDANCE OF METHADONE MAINTENANCE PATIENTS
- Trends and characteristics of buprenorphine-involved overdose deaths prior to and during the covid-19 pandemic
- “It’s like ‘liquid handcufs”: The effects of take-home dosing policies on Methadone Maintenance Treatment (MMT) patients’ lives
- A COMPARISON OF DRUG OVERDOSE DEATHS INVOLVING METHADONE AND OTHER OPIOID ANALGESICS IN WEST VIRGINIA